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Chlamydiae are Gram negative bacteria that develop exclusively inside eukaryotic host
cells, within amembrane-bounded compartment. Members of the familyChlamydiaceae,
such as Chlamydia trachomatis, are pathogenic species infecting vertebrates. They have
a very reduced genome and exploit the capacities of their host for their own development,
mainly through the secretion of proteins tailored to interfere with eukaryotic processes,
called effector proteins. AllChlamydiaceae possess genes coding for four to five effectors
that share a domain of unknown function (DUF582). Here we show that four of these
effectors, which represent the conserved set in all Chlamydiaceae, accumulate in the
infectious form of C. trachomatis, and are therefore likely involved in an early step
of the developmental cycle. The fifth member of the family, CT621, is specific to C.
trachomatis, and is secreted during the growth phase. Using a two-hybrid screen in yeast
we identified an interaction between the host protein Hrs and the DUF582, which we
confirmed by co-immunoprecipitations in co-transfected mammalian cells. Furthermore,
we provide biochemical evidence that a second domain of one of the DUF582 proteins,
CT619, binds the host protein Tsg101. Hrs and Tsg101 are both implicated in a
well conserved machinery of the eukaryotic cell called the ESCRT machinery, which
is involved in several cellular processes requiring membrane constriction. Using RNA
interference targeting proteins implicated at different stages of ESCRT-driven processes,
or inhibition by expression of a dominant negative mutant of VPS4, we demonstrated
that this machinery was dispensable for bacterial entry, multiplication and differentiation
into infectious progeny, and for uptake of glycogen into the parasitophorous vacuole. In
light of these observations we discuss how the DUF582 proteins might target the ESCRT
machinery during infection.
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INTRODUCTION
Chlamydiae are obligate intracellular bacteria that grow in
very diverse eukaryotic hosts, including humans. Chlamydia
trachomatis is the most prevalent sexually transmitted bacterial
pathogen. Infections of the urogenital mucosae often stay
asymptomatic but can lead to severe pathologies including
pelvic inflammatory disease, ectopic pregnancy, and infertility
(Brunham and Rey-Ladino, 2005). This species is also able to
colonize the eye conjunctiva, and the resulting inflammation is
the leading cause of blindness by an infectious agent (Taylor et al.,
2014).
All chlamydiae proliferate via an intracellular biphasic
developmental cycle (AbdelRahman and Belland, 2005). The
infectious forms of the bacteria, called elementary bodies
(EBs), are small and non-replicative. Upon entry into a host
cell, typically an epithelial cell, the EB converts to a larger,
metabolically more active and replicative form, the reticulate
body (RB) (Cossé et al., 2016). EBs and RBs reside within a
membrane-bound vacuole called the inclusion. After several
rounds of division, RBs convert back to the infectious form,
before ultimately exiting the host cell. Completion of the whole
cycle takes 2 or more days depending on the species.
C. trachomatis displays a genome reduced to around one
million base pairs, and relies on the host with regard to
several essential metabolic pathways (Stephens et al., 1998). Lipid
droplets and peroxisomes have been observed in the inclusion
lumen, indicating that this compartment is able to engulf large
particles (Kumar et al., 2006; Boncompain et al., 2014). Also, we
have recently shown that C. trachomatis is able to engulf glycogen
in bulk from the host cytoplasm (Gehre et al., 2016). One piece
of evidence for bulk import of cytoplasmic glycogen was the
observation of glycogen-filled vesicles in the inclusion lumen,
suggesting that the polymer was engulfed in a membrane-bound
form, through inward invagination of the inclusion membrane.
Similarly, live microscopy on the import of lipid droplets
suggested that the inclusion membrane was able to engulf
such large particles (Cocchiaro et al., 2008). The underlying
mechanism is completely unknown. Topologically speaking, it
is similar to the inward invagination of the limiting membrane
of endosomes that leads to the formation of multivesicular
bodies (MVBs), a well-studied step along endosomal maturation.
The formation of luminal vesicles in MVBs depends on a
machinery called the endosomal sorting complex required for
transport, or ESCRT (Hurley, 2010; Field et al., 2011). During
MVB biogenesis five distinct complexes (ESCRTs -0, -I, -II,
and -III, and VPS4) act sequencially to recognize and sort
ubiquitinated cargo into intraluminal vesicles (Henne et al.,
2011). In addition to their role in MVB formation, for which
they were first described, ESCRT proteins are well established
to function in cell abscission, viral budding, exosome secretion,
and autophagy (McCullough et al., 2013). The very ancient
emergence of some of the ESCRT components explains the
implication of this machinery in several core functions of the
eukaryotic cell (Field et al., 2011; Hurley, 2015). Considering the
fact that parasitism of eukaryotic cells by Chlamydiae is also a
very ancient event (Horn et al., 2004), the bacteria may have
acquired mechanisms to co-opt this machinery to sustain its own
development.
Chlamydiae devote a large proportion of their small genome
to the synthesis of proteins secreted into the host cytoplasm. By
doing so, they hijack key cellular pathways and host resources
for their own need. Among its different secretion machineries
chlamydiae have privileged the type 3 secretion system for the
translocation of proteins into the inclusion lumen and into the
cytoplasm (Subtil et al., 2005; da Cunha et al., 2014; Mueller
et al., 2014). In particular we have identified, as type 3 secretion
substrates, a family of proteins conserved in all pathogenic strains
with a common domain numbered DUF582 (Muschiol et al.,
2011). TheC. trachomatis genome encodes five DUF582 proteins,
CT619, CT620, CT621, CT711, and CT712, that are expressed
at mid- to late-cycle (Belland et al., 2003). CT620 and CT621
were detected in the host cytoplasm, and CT620 and CT711
were also detected in the nuclei of infected cells (Muschiol et al.,
2011). The follow-upwork described in the present paper pointed
to the ESCRT-0 component Hrs as a potential partner. Hrs,
together with its partner STAM, forms the ESCRT-0 complex.
Both proteins bind ubiquitinated cargo. Through this activity,
and their ability to bind early endosomes, they control the
first step of sorting of ubiquitinated cargo toward intraluminal
vesicles. Hrs also makes the link with the second step of cargo
sorting through its ability to bind one subunit of the ESCRT-I
complex, Tsg101.
The potential interaction between one DUF582 domain and
Hrs, together with the attractive hypothesis that the ESCRT
machinery might be involved in the uptake of cytoplasmic
material by the inclusion, prompted us to investigate whether the
ESCRT machinery was required for chlamydial development.
MATERIALS AND METHODS
Cells and Bacteria
HeLa cells and HEK-293 cells (ATCC) were cultured in
Dulbecco’s modified Eagle’s medium with Glutamax (DMEM,
Invitrogen), supplemented with 10% (v/v) fetal bovine serum
(FBS).C. trachomatis LGV serovar L2 strain 434 (ATCC), or GFP-
expressing L2 (GFPCtrL2) (Vromman et al., 2014) were purified
on density gradients as previously described (Scidmore, 2005).
Yeast-Two-Hybrid (Y2H) Assays
The Y2H screens were performed by Hybrigenics (Paris, France).
Two baits were used corresponding to the DUF582 domain of
CT619 (CT619Cter, amino acids 480–877) and to the N-terminal
domain (amino-acids 1–490). For each screen, a minimum of
7.107 interactions between the bait and a human placenta library
were tested.
Interactions were further tested using the Matchmaker kit
(Clontech) following the manufacturer’s guidelines. The DUF582
protein constructs were cloned into the yeast vector pGBKT7
carrying the GAL4 DNA binding domain while the Hrs
constructs were cloned into the pGADT7 vector carrying the
GAL4 activation domain. The primers used to make these
constructs are listed in the Table S1. The yeast strain AH109
was transformed with the two vectors simultaneously and plated
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on double dropout medium (DDO; SD/-Leu/-Trp) for 48 h at
30◦C. Single colonies were then cultured over-night at 30◦C in
a YPDmedium and from this culture a serial dilution of the same
number of yeast was plated on selective media DDO and QDO
(SD/-Ade/-His/-Leu/-Trp). Results were analyzed 48 h later.
Transfections of Plasmids or siRNA
Cells were transfected with the indicated plasmids 24 h after
seeding using JetPrime transfection kit (Polyplus transfection)
following the manufacturer’s instructions. For gene silencing,
10 nM (final concentration) of siRNA (Dharmacon) was mixed
with Opti-MEM (Invitrogen) and Lipofectamine RNAiMAX
reagents (Invitrogen) and added to 80,000 HeLa cells in
suspension in complete medium. The cells were subsequently
seeded in 24-well plates. Transfection was performed twice, 48
and 4 h prior to infection. siRNA efficiency was determined
by immunoblot or RT-PCR (see respective sections for
details). The siRNA sequences used were the following: control
UGGUUUACAUGUCGACUAA, Hrs (1) GAACCCACACGU
CGCCUUG, Hrs (2) GAGGUAAACGUCCGUAACA, Tsg101
(1) CCAGUCUUCUCUCGUCCUA, Tsg101 (2) GAAGUA
GCCGAGGUUGAUA, Chmp4BAGAAAGAAGAGGAGGACG
A (Guizetti et al., 2011).
Cloning Procedures
The genes coding the five DUF582 proteins (CT619, CT620,
CT621, CT711, CT712) were amplified from C. trachomatis
D/UW-3/CX genomic DNA by PCR with Phusion high-fidelity
DNA polymerase (Finnzyme) according to the manufacturer’s
instructions and cloned into a pEGFP-derived destination vector
providing a N-terminal green fluorescent protein (GFP) tag
using the Gateway technology. The primers used to make
these constructs are listed in the Table S1. Other constructs
were generously provided by F. Gesbert (Université Paris Sud,
Villejuif, France, myc-Hrs), E.O Freed (NIH Bethesda, USA, HA-
Tsg101 constructs; Goila-Gaur et al., 2003), J. Martin-Serrano
(King’s College London School of Medicine, London, UK, VPS4
constructs).
Production and Purification of
Recombinant Protein for Antibody
Production
The full length gene of ct712 and the region of ct619 truncated
of the first 81 and last 625 codons were amplified by PCR,
and were cloned using the Gateway system into the pDEST15
(Invitrogen) destination vector, providing a GST tag at the N-
terminus. Expression of the recombinant proteins was made after
transformation of BL21 E. coli strain. BL21 bacteria transformed
with the GST-181CT6191625 construct were cultured in LB
media supplemented with ampicillin at 37◦C until the optical
density at 600 nm reached 0.6 before addition of isopropyl β-
D-1-thiogalactopyranoside (IPTG) for expression induction. The
GST-CT712 construct was obtained from cultures in micro-
fermentors to overcome low yields. Protein purification was
performed on column using glutathione-sepharose beads (GE
Healthcare) following the manufacturer indications. Purified
proteins were used to immunize New Zealand White rabbits
for production of polyclonal antisera (AgroBio, La Ferté Saint-
Aubin, France). To test these antibodies by western blot, cell
lysates or purified EBs were lysed in 8M urea, 1% SDS (v/v),
150mMNaCl, 30mMTris pH 8.0 and the proteins were analyzed
by SDS-PAGE as described below.
Immunofluorescence and Western Blot
For immunofluorescence (IF), HeLa cells fixed for 30min
at room temperature in paraformaldehyde (PFA) 4% (w/v)
in PBS were permeabilized for 15min in PBS supplemented
with 1mg/ml bovine serum albumin (BSA) and 0.05% (w/v)
saponin (IF buffer). For anti-Hrs staining, cells were fixed for
30min on ice in PFA 4%. For CT813 staining, cells were
fixed 30min at room temperature in PFA 2%. Coverslips were
incubated with primary antibodies in IF buffer for 1 h at room
temperature, followed with three washes in the same buffer.
Primary antibodies used for IF were: mouse Anti-Hrs (clone
A-5, Enzo Life Science), rabbit anti-Myc (ab9106, Abcam),
rabbit anti-CT529 (Gehre et al., 2016), mouse anti-CT813
(kind gift from G. Zhong, University of Texas), rabbit anti-
Gys1 (04-357, Millipore). Secondary antibodies coupled with
a fluorophore were incubated for 1 h together with 0.5µg/ml
Hoechst 33342 (Molecular Probes) in IF buffer. Coverslips were
then mounted in Mowiol buffer and analyzed using an Axio
observer Z1 microscope equipped with an ApoTome module
(Zeiss, Germany) and a 63× Apochromat lens. Pictures were
taken with a Coolsnap HQ camera (Photometrics, Tucson, AZ)
using the software Axiovision.
For western blot analyses, cells were lysed in 1% (v/v)
sodium dodecyl sulfate (SDS), 8M urea, 150mM NaCl, and
30mM Tris-HCl pH 8. Samples normalized to protein content
were analyzed by sodium dodecyl-sulfate poly-acrylamide gel
electrophoresis (SDS-PAGE). Proteins were transferred on
polyvinylidene difluoride (PVDF) membranes and incubated
for 1 h in 0.1% Tween-20 (v/v) in PBS supplemented with 5%
(w/v) skimmed milk. Primary and secondary antibodies were
both sequentially incubated in 0.1% Tween-20 in PBS 1X on
the membranes for 1 h separated by washes. Primary antibodies
used were: rabbit anti-Hrs (Bethyl laboratories), mouse anti-
Tsg101 (clone 4A10, GeneTex), anti-GFP (sc-8334, Santa-Cruz),
and anti-HA.11 (clone 16B12, Covance), mouse anti-myc (clone
9E10, Santa-Cruz). For qualitative analysis, secondary antibodies
were coupled with horse-radish peroxidase and were revealed by
chemiluminescence (KODAK).
Quantification of Bacterial Entry
Entry experiments were performed as described (Vromman
et al., 2014). Briefly, HeLa cells were incubated at 4◦C for
15min in DMEM 10% FCS (v/v) before adding the GFPCtrL2
(multiplicity of infection (MOI) = 10) for another 30min at
4◦C. Medium was replaced by pre-warmed medium at 37◦C, and
plates were transferred to the 37◦C incubator for the indicated
times before fixation in ice-cold 4% PFA in PBS for 30min.
Extracellular bacteria were stained with a mouse anti-MOMP-
LPS (Argene #11-114) antibody followed with Cy5-conjugated
secondary antibodies. Pictures of fields with 5-10 cells were
acquired and analyzed as described (Vromman et al., 2014).
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Analysis of Infection by Flow Cytometry
Cells were infected with density gradient purified GFPCtrL2 EBs
at a MOI < 0.3. Twenty-four hours later, cells were washed with
PBS and gently detached using 0.5mM EDTA in PBS. Samples
were fixed in PFA 2% in PBS and stored over-night at 4◦C. Flow
cytometry analysis was performed with a FACS Gallios (Beckton
Coulter) using the FL-1 (detecting fluorescence emission between
505 and 545 nm), the FSC (relative cell size) and the side scatter
detectors (cell granulometry or internal complexity) on 1/10 of
the sample diluted in PBS. A minimum total of 10,000 gated
events were collected for each sample. Data were analyzed using
the Kaluza 1.2 software (Beckman Coulter).
The analysis of cells transfected with myc-tagged VPS4 was
performed in the following way: after fixation, the cells were
centrifuged at 1500 g, washed in PBS, centrifuged again, and
incubated for 1 h with rabbit anti-myc antibodies in 1mg/ml
BSA, 0.05% saponin in PBS. The cells were then washed and
incubated for 1 h in the same buffer with anti-rabbit antibodies
conjugated to Cy5. After another washing step the cells were
resuspended in PBS and analyzed by flow cytometry in the FL-1
(green) and FL-4 (far-red) channels.
To measure progeny, cells were washed in PBS 24 h post-
infection (hpi), detached and lysed with 1mm glass beads. Fresh
HeLa cells were inoculated with serial dilutions of the cell lysates
and 24 h later flow cytometry was used to determine the infection
rate and deduce inclusion forming units (ifu) in the inoculum.
Immunoprecipitation (IP)
HEK-293 cells were lysed on ice for 45min in ice cold 150mM
NaCl, 10mMNaF, 1mMEDTA, 1mMEGTA, 0.5% Triton X-100
(v/v), 50mM Tris pH 7.5 (IP buffer) supplemented with 5mM
PMSF, 1mM vanadate and 1:100 of proteases inhibitor cocktail
(P8340, Sigma). Cells were removed with a scraper, homogenized
and centrifuged at 16000 g for 20min at 4◦C. For anti-myc
IP, the supernatant was incubated at 4◦C for 1–2 h with anti-
myc 9E10 antibody (Santa-Cruz) followed by a 1.5 h incubation
with protein G coupled to sepharose-beads. For anti-HA IP, the
supernatant was incubated for 2 h with the anti-HA antibody
coupled to agarose beads (Sigma) at 4 C. Immunoprecipitates
were then washed at 4◦C for a minimum of 5 times with 1mL
of the IP buffer with gentle centrifugations of maximum 400 g.
Beads were then resuspended in a Laemmli buffer supplemented
with 1% ß-mercapto-ethanol (v/v).
Reverse Transcription PCR
Total RNA was isolated with the RNeasy Mini Kit with DNase
treatment (Qiagen) according to the manufacturer’s protocol at
the indicated times after transfection with control or Chmp4B
siRNA. RNA concentrations were determined by NanoDrop
and the samples normalized to an equal RNA content. Reverse
transcription (RT) was performed with SuperScript III Reverse
Transcriptase (Life Technologies) and cDNA was used as
a template for amplification of Chmp4B with PrimeStar
(Clontech) using GAGTTCCTGGAGAAGAAAATCG and
CCTCTTCTTACGCTTCAGTGC as primers. Equal volumes
were loaded on agarose gels and bands were revealed using
UV-light visualizing ethidium bromide.
RESULTS
The DUF582 Domain Interacts with Hrs
A two-hybrid screen in yeast using the DUF582 domain of CT619
as bait identified 10 putative partners, with moderate to high
scores of confidence. The best score was assigned to only two
proteins: dynamin 2 and Hrs. Attempts to detect an interaction
between CT619 and dynamin 2 by co-immunoprecipitation
failed, and this direction was not pursued any further. The
DUF582 domain is predicted to be mainly α-helical and to
contain a segment adopting a coiled-coil conformation. It is
only moderately conserved, with an amino acid identity ranging
from 18% (CT711–CT712) to 39% (CT620-CT621) (Figure 1B
and Muschiol et al., 2011). We reasoned that if, in spite of
this low conservation, we could detect an interaction between
Hrs and the DUF582 domain of other members of the family,
this would considerably strengthen the hypothesis that Hrs is
a true interactor of the domain. To test this, we fused the
DUF582 domains of CT619, CT621, CT711, and CT712 of
C. trachomatis L2 to the Gal4 binding domain coded by the
pGBKT7 vector (CT620 was not tested in this assay). Full-length
Hrs, or its minimal interacting domain found in the screen
using the DUF582 of CT619 as bait, 1368Hrs1138, were fused
to the Gal4 activation domain coded by the vector pGADT7
(Figure 1A). Yeast were co-transformed with each plasmid and
plated on selective medium for isolation of co-transformed cells.
Dilutions of the same quantity of co-transformed yeast were
plated on high stringency medium (quadruple dropout) to reveal
positive interactions (Figure 1C). All of the DUF582 domains
tested, except that of CT621, showed an interaction with Hrs in
this experimental system. For all cases where an interaction was
observed, it appeared to be stronger when the shorter form of
Hrs,1368Hrs1138, rather than the full-length form, was tested.
To delimit further the interaction between CT619 and Hrs,
we tested truncated versions of the DUF582 domain of CT619.
We generated the construct CT619Cter189, in which the last 89
amino acids, that correspond to the most conserved region in the
DUF582 (Muschiol et al., 2011), were deleted. We also designed
a construct truncated for the last 191 amino acids (CT619Cter
1191), which no longer contains the coiled coil region common
to all DUF582 (Muschiol et al., 2011). Surprisingly, none of
these truncations had an impact on the interaction with Hrs
(Figure 1D). Thus, we concluded from these experiments that the
ability to interact with Hrs is conserved between several DUF582
domains and does not involve the C-terminal part of this domain.
To document this interaction with another technique we
investigated the localization of GFP-tagged DUF582 proteins, in
conditions where Hrs was overexpressed or not. When expressed
alone, the GFP-tagged DUF582 proteins were uniformly
distributed throughout the cytoplasm. When myc-Hrs was
co-expressed, in the majority of the cells the distribution
of the GFP-tagged proteins was no longer uniform, but
accumulated in structures of various sizes (Figure 2A). The
change in the distribution of the DUF582 proteins when Hrs
was overexpressed, and their partial co-localization, support
the hypothesis that the proteins interact. We tested this
by co-immunoprecipitation experiments in HEK-293T cells
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FIGURE 1 | Interaction between the DUF582 and Hrs probed by two-hybrid in yeast. (A) Schematic view of the constructs used. Full length Hrs, or the minimal
domain interacting with CT619 identified in the two-hybrid screen, 1368Hrs1138, were cloned in the pGADT7 vector. For the four chlamydial proteins tested, only the
corresponding DUF582 (hatched box) were cloned in the pGBKT7 vector. (B) Percentage of identity between amino acids within the DUF582 domain of
C. trachomatis DUF582 proteins (C) Illustration of one negative (CT621Cter) and one positive (CT712) interaction, and summary of the yields of yeast observed in the
different combinations tested. (D) Summary of the yields of yeast observed when the last 89 or 191 amino acids of CT619Cter were deleted.
overexpressing myc-Hrs together with various GFP-tagged
proteins (Figure 2B). In these experiments a GFP-tagged
fusion with an irrelevant chlamydial protein of similar size,
GFP-CT671, was used as a negative control. No interaction
was detected between this protein and myc-Hrs. In contrast,
all the DUF582 proteins co-immunoprecipitated with myc-Hrs,
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FIGURE 2 | Interaction between the DUF582 and Hrs probed by co-expression in mammalian cells. (A) HeLa cells were transfected to express GFP alone or
GFP-tagged DUF582 proteins, either alone (left) or together with myc-Hrs (right). One day later, the cells were fixed in 4% PFA and stained with rabbit anti-myc
antibody, followed with a secondary Cy5-conjugated anti-rabbit antibody. DNA, labeled in blue, is shown on the merged picture. Scale bar = 10µm. (B) HEK-293
cells were transfected with myc-Hrs and the indicated construct for 24 h, lysed and immunoprecipitated with anti-myc antibody. Proteins were separated on
SDS-PAGE, transferred on a PVDF membrane and probed with the indicated antibody. An aliquot of each cell lysate was loaded on a separate gel to compare the
expression level of each of the GFP-tagged proteins (input) and an aliquot of the immunoprecipitated fraction was loaded on a separate gel to assess the efficiency of
the immunoprecipiation using anti-myc antibodies. IB, immunoblot; IP, immunoprecipitation.
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including GFP-CT620, which had not been tested in the two-
hybrid assay and colocalized with myc-Hrs. When only the
DUF582 domain of CT619 was used, it was expressed at a lower
level than the full-length protein and co-immunoprecipitated
with myc-Hrs relatively better. Thus, it is possible that the
DUF582 domain is somehow less accessible for Hrs binding
when expressed in the full-length protein. Interestingly, we also
detected an interaction between Hrs and CT621 or its DUF582
domain alone. It is consistent with the relocation of GFP-CT621
upon myc-Hrs co-expression reported above and indicates that,
in spite of the negative result obtained in the two-hybrid screen,
the DUF582 of CT621 is also able to bind the ESCRT-0 protein.
CT619 Also Interacts with the ESCRT-I
Protein Tsg101
A second two-hybrid screen in yeast, this time using the N-
terminal domain of CT619 as bait, generated 20 hits with
moderate to high confidence scores. Eleven proteins came out
with the highest score: Bin3, Dact2, Dynamin-2, HMG20B,
Keratins 8 and 19, PMC1, PHF16, RCN1, SPTB1, and Tsg101.
The latter is a well-studied component of the ESCRT-I complex,
and binds to Hrs. From the different clones obtained, that showed
an interaction with the N-terminal domain of CT619, we inferred
that the domain of interaction was comprised within the amino
acids 168 and 282 of Tsg101, thus including parts of the proline-
rich region and the coiled-coil domain (Figure 3A).
To verify this interaction, we performed immunoprecipitation
experiments using truncated HA-tagged Tsg101 constructs
(Figure 3A). HEK-293T cells were transfected with HA-tagged
Tsg101 constructs alone or together with GFP-tagged CT619.
Full-length HA-tagged Tsg101 was expressed at a very low level
and was not included in these experiments. Immunoprecipitation
was performed with anti-HA antibodies coupled to agarose
beads. Inputs and immunoprecipitated fractions were analyzed
by western blot with anti-HA and anti-GFP antibodies. CT619
co-immunoprecipitated with the two constructs of Tsg101 that
contained the coiled-coil domain (Figure 3B). Using constructs
that expressed separately the amino-terminal domain of CT619
(GFP-CT619Nter) or its DUF582 domain (GFP-CT619Cter), we
confirmed that the interaction between Tsg101 and CT619
implicates the N-terminal domain of CT619. In contrast, CT621,
whose N-terminal domain shows no similarity with the one of
CT619 (Muschiol et al., 2011), does not interact with the Tsg101
construct containing the coiled-coil domain, nor with the shorter
construct that was used as a negative control (Figure 3C).
Altogether, these data demonstrate specific interactions of the
ESCRT-I protein Tsg101 and of the ESCRT-0 protein Hrs with
the N-terminal and C-terminal domains of CT619, respectively,
strengthening the hypothesis that CT619 targets an ESCRT-
driven pathway.
Depletion of Hrs or of Tsg101 Does Not
Affect C. trachomatis Internalization
To gain further insight into the function of the DUF582 proteins
we completed our toolbox by generating polyclonal antibodies
against CT619 and CT712 (Figure 4A). Like CT620 and CT711
(Muschiol et al., 2011), CT619 runs in denaturing gels as a double
band, with the higher, minor, band corresponding to the expected
molecular weight, and a 10 kD-shorter, major, species. CT712
migrates as a single species of expected size. CT619 and CT712
accumulated late in infected cells and were abundant in EBs
(Figure 4B), a pattern of expression similar to that of CT711
and CT620. In contrast, CT621 was detected earlier (16 hpi) and
was less abundant in EBs. Several type 3 secretion effectors are
enriched in EBs (Saka et al., 2011), that are likely secreted in the
early stages of infection, to facilitate entry and secure the nascent
inclusion. By immunofluorescence, we did not detect any of the
DUF582 proteins at an early stage of infection, possibly because
the amount of effector secreted was too low for detection by
this method (data not shown). At later time points we detected
CT620 and CT621 in the host cytoplasm of some of the infected
cells (Muschiol et al., 2011), but not the other DUF582 proteins
(data not shown). Again, we cannot rule out the possibility that
their secretion is below the sensitivity of this technique. Having
shown that CT619 interacts in vitro with Hrs and Tsg101 we
asked whether these proteins of the ESCRT machinery were
required for the internalization step. Each of the two proteins was
depleted for 24 h using two different siRNAs. Immunoblotting
with specific antibodies revealed a depletion of at least 85% for
each protein. Twenty-four h after depletion cells were infected
with GFP-expressing C. trachomatis L2 (GFPCtrL2, MOI = 10),
and fixed 1 h later. Extracellular bacteria were stained using anti-
MOMP antibody and internalized bacteria were quantified using
a semi-automated image analysis software (Vromman et al.,
2014). No difference in the efficiency of entry was observed in
the cells depleted for Hrs or Tsg101 compared to control cells
(Figure 5A).
C. trachomatis Development Proceeds
Normally In vitro in the Absence of Hrs or
Tsg101
By immunofluorescence we observed that Hrs was often present
in the vicinity of the inclusion membrane, although it did
not appear to be enriched at this location (Figure S1). It
might transiently associate with the inclusion membrane and
contribute to its exchanges with the host cytoplasm. We thus
tested whether impairing ESCRT-driven pathways would impact
bacterial growth. Control cells and cells depleted for Hrs or
Tsg101 were infected with GFPCtr L2 at MOI = 1. Twenty h
later cells were fixed and analyzed by flow cytometry (Vromman
et al., 2014). Similar infection rates were observed in all samples,
confirming that depleting Hrs or Tsg101 has no impact on
bacterial entry (Figure 5B). In addition, GFP, a read-out of
bacterial growth (Vromman et al., 2014), accumulated to the
same extent in all conditions, indicating that Hrs and Tsg101 are
not required for bacterial growth in vitro (Figure 5B).
Disruption of Late Steps of the ESCRT
Machinery Does Not Affect C. trachomatis
Development
Hrs and Tsg101 are part of the ESCRT-0 and -I machineries,
respectively, which sort cargo to the finale ESCRT-III driven
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FIGURE 3 | The ESCRT-I protein Tsg101 interacts with CT619. (A) Schematic view of the domains in Tsg101. The minimal region of interaction with CT619
identified in the two-hybrid screen is boxed. The four HA-tagged constructs used are schematized below. (B) HEK-293 cells were transfected with HA-tagged Tsg101
constructs alone or together with GFP-CT619 for 24 h, lysed and immunoprecipitated with anti-HA antibody coupled to agarose beads. Proteins were separated on
SDS-PAGE, transferred on a PVDF membrane and probed with anti-GFP antibody. An aliquot of each cell lysate before (L) of after the immunoprecipitation (Un for
Unbound) was loaded on a separate gel to compare the expression level of each of the proteins (Input, left, only shown for the co-transfections). IB, immunoblot; IP,
immunoprecipitation. GFP-CT619 co-immunoprecipitated with the constructs Tsg320 and Tsg3’, which include the coiled-coil domain of Tsg101. (C) Same as in B,
with co-expression of HA-tagged Tsg101 constructs together with GFP-CT621, the DUF582 of CT619 (GFP–CT619Cter), or with its N-terminal domain
(GFP-CT619Nter). Only the latter interacts with the Tsg320 construct.
step. Alternative adaptors appear to work upstream of ESCRT-III
(Bissig and Gruenberg, 2014). Thus, to directly test if a functional
ESCRT-III machinery was required for chlamydial growth we
used a siRNA against Chmp4B, an essential component of
the ESCRT-III complex (Hurley, 2010). The efficiency of the
siRNA was verified by RT-PCR 24, 48, and 72 h post-transfection
(Figure 6A). In addition, we examined the distribution of
the epidermal growth factor (EGF) receptor using fluorescent
EGF. Upon internalization with its ligand, the EGF receptor
is processed by the ESCR-0, -I, -II, and -III machineries for
finale sorting to multiversicular bodies (Henne et al., 2011).
Depletion of ESCRT components alter the morphology of
these compartments (Razi and Futter, 2006). Cells depleted for
Chmp4 were loaded for 15min with 100 ng/ml rhodamine-
coupled EGF (EGFRho), washed and incubated further at 37◦C
for 45min before fixation. After treatment with siRNA against
Chmp4B EGFRho positive compartments were fewer and more
dispersed than in cell treated with control siRNA, confirming
that this siRNA is efficient at disturbing Chmp4 mediated
pathways (Figure S2). Cells were infected with GFPCtrL2 at
MOI = 1 24 h after the transfection with siRNA, and fixed
and analyzed 24 h later by flow cytometry. Cells depleted for
Chmp4B showed similar infection rates and bacterial load as
control cells (Figure 6A), indicating that Chmp4B is not required
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FIGURE 4 | All DUF582 proteins, except CT621, accumulate in EBs. (A)
Cell lysates from uninfected cells or cells infected for 32 h, and gradient
purified EBs, were lysed in 8M urea buffer (see methods). Proteins were
separated on SDS-PAGE (10% for CT619, 12% for CT712), transferred on a
PVDF membrane and probed with the indicated rabbit polyclonal antibody.
CT619 (expected mw = 97 kD) runs as a double band, while CT712
(expected mw = 44 kD) runs as a single species. (B) HeLa cells were infected
with C. trachomatis L2 for the indicated times before lysis in 8M urea buffer.
Gradient purified EBs, lysed in the same buffer, were loaded in the right lane
for comparison. Identical samples were loaded on separate gels and probed
with the indicated polyclonal rabbit antibodies. Actin was used as a loading
control, and also shows the good purification of the EBs. CT712 expression is
hardly detected. This might reflect a low expression, and/or sub-optimal
detection with this antibody.
for bacterial growth. Finally, to rule out the possibility that the
levels of depletion obtained with the siRNA against Hrs, Tsg101,
or Chmp4B, although clearly significant (see Figure S2 for
functional validation of the siRNA against Hrs and Tsg101), were
not sufficient to completely block ESCRT-mediated processes,
we used a dominant negative form of VPS4, which prevents
the disassembly of the ESCRT machinery at the end of the
process, and is considered as the most potent method to inhibit
ESCRT-mediated steps. Indeed the traffic of EGFRho was deeply
affected by the expression of a dominant negativemutant of VPS4
(mutation K173 to Q) (Figure S2). HeLa cells were transfected
with myc-tagged VPS4 constructs, wild type (WT) or dominant
negative (DN), and infected 4 h later (to avoid excessive cell
death upon expression of VPS4-DN). Cells were fixed 24 hpi
and analyzed by flow cytometry. If anything, a slight increase in
the percentage of infection was observed in the cells expressing
myc-VPS4-DN compared to cells expressing the wild-type form.
Bacterial loads were similar in both conditions (Figure 6B). This
experiment confirms that functional ESCRT is not required for
chlamydial growth.
Finally, we asked if impairing ESCRT-0, -I, or -III had an effect
on the infectious progeny. We measured it on progeny collected
24 hpi, since prolonged (>72 h) depletion of the ESCRT proteins
affected cellular viability in some of the experiments. Depletion of
Hrs, Tsg101 or Chmp4B had no effect on the infectious progeny
(Figure 6C), indicating that the whole infectious cycle proceeds
normally in cells deficient for ESCRT functions.
Import of Cytosolic Glycogen Synthase Is
Not Dependent on the ESCRT Machinery
We have recently shown that host glycogen translocates into
the inclusion lumen, where it contributes to glycogen storage
within the inclusion lumen. The host glycogen synthase Gys1
was also observed inside the inclusion lumen. This enzyme is
known to associate with glycogen particles (Stapleton et al.,
2010). When cytoplasmic glycogen levels were reduced by
depriving the cells of glucose Gys1 translocation was also strongly
reduced, supporting the hypothesis that Gys1 makes its way
to the inclusion lumen bound to cytoplasmic glycogen (Gehre
et al., 2016). The mechanism by which host glycogen/Gys1
reaches the inclusion lumen is unknown. By electron microscopy
we observed glycogen-filled vesicles in the inclusion lumen,
supporting a transport through the inward budding of vesicles
from the inclusion membrane. Since this would fit with the
topology of inward vesicle budding from the periphery of MVBs
we hypothesized that the ESCRT machinery might be involved.
To test this we silenced Hrs, Tsg101, or Chmp4B expression
for 2 days before infecting the cells with C. trachomatis L2.
Cells were fixed 24 h later, permeabilized, and the inclusion
membrane and Gys1 were labeled with mouse anti-CT813 and
rabbit anti-Gys1 antibodies, respectively. Strong reduction in
Hrs, Tsg101, or Chmp4B levels did not impair Gys1 translocation
into the inclusion lumen when compared to control cells
(Figure 7), implying that the ESCRT-0, -I, and -III machineries
are dispensable for this process.
DISCUSSION
The aim of the present work was to understand the function of
a family of type 3 secretion substrates of Chlamydiaceae, which
shared a domain restricted to this family, called DUF582. The
domain showed only limited sequence identity betweenmembers
of the family, and this feature incited us to use it as a lead for
the functional study of the family. Using two-hybrid in yeast as a
read-out for protein interaction we identified Hrs as a potential
interactor for three DUF582 domains (those of CT619, CT711,
and CT712). This finding was strengthened by the observation
that co-expression of Hrs modified the distribution of each of the
five DUF582 proteins ofC. trachomatiswhen they were expressed
in HeLa cells, and that the two proteins co-localized to some
extent. In addition the DUF582 proteins co-immunoprecipitated
with Hrs. Furthermore, the link between DUF582 proteins and
the ESCRT pathway was strongly reinforced in the case of CT619,
as the N-terminal domain of the protein interacted with a second
protein of the pathway, Tsg101, both by two-hybrid and by
co-immunoprecipitation in transfected cells.
In spite of this biochemical evidence for an interaction
between the DUF582 domain and Hrs (and Tsg101 for CT619)
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FIGURE 5 | Hrs and Tsg101 are dispensable for chlamydial entry and development. HeLa cells were transfected for 48 h with siRNA targeting Hrs or Tsg101
(two different siRNA for each target) before infecting the cells with GFPCtrL2. NT = not transfected, CTRL = transfected with control siRNA. (A) Sixty min after
infection the cells were fixed, and extracellular bacteria were stained with anti-MOMP antibody, followed with Cy5-conjugated anti-mouse antibodies. The top panel
shows the level of expression of Hrs and Tsg101 in cell lysates 24 h after the transfection revealed by western blot. Staining with antibodies against actin is shown as
loading control. The middle panel depicts one representative field of the internalization assay, scale bar = 5µm. Quantification of the internalized bacteria using the
ICY software (Vromman et al., 2014) (>70 bacteria analyzed per condition) is presented in the histogram below. (B) Twenty-four h after infection the cells were fixed,
and analyzed by flow cytometry. The top panel shows one representative sample: the level of green fluorescence (x axis, FL1) discriminates non-infected (left peak)
from infected (right peak) cells. The middle panel shows the percentage of infected cells in the different conditions tested, and the lower panel shows the mean green
fluorescence of the infected population. Values are the mean of three independent experiments, error bars represent the standard deviation.
we could not demonstrate its relevance in an infectious context.
Three main limitations might explain the lack of direct evidence
for a link between the DUF582 proteins and manipulation of the
ESCRT machinery during infection.
First of all, the DUF582 proteins are of low abundance.
Only CT619 and CT711 were detected in the first quantitative
proteomic study performed on C. trachomatis (Saka et al.,
2011). Recently, CT619, CT620, and CT621 were detected by
proteomics, still within the low range in terms of molecules
per bacterium (Skipp et al., 2016). Thus, it is unlikely that the
secreted effectors are present in sufficient amount to globally
disturb ESCRT-dependent processes, even more so when only a
fraction of the pool might be translocated into the host cytoplasm
at any given time. Indeed, we did not observe any major change
in Hrs distribution during the infectious cycle, and we could not
co-immunoprecipitate any of the DUF582 proteins together with
Hrs in an infectious context.
Secondly, it is likely that the DUF582 proteins (with the
exception of CT621, see below) are secreted at a very early step
of infection, and are therefore present in minute amount in the
host cytoplasm, challenging detection of the endogenous proteins
and their activities. Indeed we demonstrated in this study using
specific antibodies that CT619, CT620, CT711, and CT712 are
enriched in EBs, consistent with a recent study of gene expression
networks in Chlamydiae showing that the four genes are co-
regulated (Domman and Horn, 2015). CT621, a C. trachomatis
specific protein, is expressed earlier and is relatively less abundant
in EBs. It is thus probably secreted only during the replication
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FIGURE 6 | ESCRT components are dispensable for completion of the developmental cycle in vitro. (A) HeLa cells were transfected for 48 h with siRNA
targeting Chmp4B or a control sequence before infecting the cells with GFPCtrL2 and performing a second transfection of the same siRNA. Twenty-four h after
infection the cells were fixed, and analyzed by flow cytometry. The left panel shows that the level of Chmp4B transcripts is strongly decreased as early as 24 h after the
transfection with siRNA targeting this gene, and the depletion persists over the time of the experiment. The middle panel shows the percentage of infection, and the
right panel shows the mean green fluorescence of the infected population. Values are the mean of three independent experiments, error bars represent the standard
deviation. (B) HeLa cells were transfected with the WT or dominant negative (DN) form of myc-tagged VPS4, and infected with GFPCtrL2 24 h later. Twenty-four h after
infection the cells were fixed, permeabilized and stained with anti-myc antibody followed with Cy5-coupled secondary antibodies, and were analyzed by flow
cytometry (Cy5 and GFP appear in the FL4 and FL1 channels respectively). One representative experiment is shown on the left, the average of 3 measurements is
shown on the right (± standard deviation), T-test show no significant difference in the infections rates between transfected and non-transfected samples. (C) HeLa
cells were transfected for 48 h with siRNA targeting Chmp4B or control sequence before infecting the cells with GFPCtrL2. Twenty-four h after infection bacteria were
collected and progeny was quantified in a reinfection assay. Values are the mean of three independent experiments (± standard deviation).
phase, a stage at which it was observed in the host cytoplasm
(Muschiol et al., 2011). In contrast, it is likely that secretion
of the four other DUF582 proteins starts just after the entry
step, as for other pre-packed effectors (Cossé et al., 2016).
We did not detect early secretion with our antibodies, likely
because the proteins were not abundant enough. We generated
a stable C. trachomatis L2 strain expressing CT619 fused to a
C-terminal FLAG tag, but could only achieve a low expression
of the protein, which was only detected in a few bacteria
per inclusion, precluding its use in immuno-localization assays
(data not shown). We occasionally observed endogenous Hrs in
the immediate vicinity of internalized bacteria, supporting the
hypothesis that an interaction between Hrs and DUF582 proteins
might occur at an early step of the developmental cycle, possibly
transiently. However, the frequency of these observations was
too low to rule out that they occurred by chance, and further
experimentation will be needed to test this hypothesis. Finally,
it is unclear how the interaction between the DUF582 domain
and Hrs relate to our previous detection of CT620 and CT711
in the nuclear fraction of infected cell (Muschiol et al., 2011),
since to the best of our knowledge there is no evidence for nuclear
location for Hrs.
Thirdly, as discussed below, we provide evidence here
that the ESCRT machinery is not required for C. trachomatis
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FIGURE 7 | Disruption of the ESCRT machinery does not impair the
translocation of the host glycogen synthase into the inclusion lumen.
HeLa cells were transfected for 48 h with siRNA targeting the indicated targets
before infecting the cells with CtrL2. Transfection was repeated 4 h after
infection to ensure prolonged silencing of the targets. Cells were fixed 20 hpi in
2% PFA and permeabilized. The inclusion membrane was stained in red using
antibodies against CT813, followed with Cy3-coupled anti-mouse secondary
antibodies, and the host glycogen synthase was stained in green using rabbit
antibodies followed with Alexa488-coupled secondary antibodies. Z-sections
were taken throughout the volume of the inclusions and the pictures show one
central slice in the inclusion volume. In all conditions examined Gys1 positive
particles were observed inside the lumen of the inclusion. Scale bar = 5µm.
development in vitro, indicating that rather than hijacking an
ESCRT-driven host mechanism, the DUF582 domain might
disable an ESCRT-driven function that would otherwise be
detrimental to the bacteria. In that case, silencing ESCRT
proteins would only reproduce what occurs normally, explaining
the absence of phenotype on infection. An overexpression
strategy cannot be used to test this hypothesis because
overexpression of the ESCRT proteins disrupts most ESCRT-
driven functions. Future work could consider generating
strains knocked-out for one of the DUF582 proteins. We
failed at generating CT619 deletion mutants, possibly
because of technical shortcomings. In any case, the possible
redundancy between the DUF582 proteins might require
silencing of several genes simultaneously, a challenging
prospect.
Thus, the relevance of the DUF582/ESCRT interaction in
infection remains to be demonstrated. Future experimentation
could consider the following hypotheses.
(i) Hypothesis 1: DUF582 proteins target Hrs/Tsg101 to escape
lysosomal degradation. It is established that at least some of the
receptors that chlamydiae use to bind to host cells are targeted
to degradation after endocytosis. For instance C. trachomatis
and C. pneumoniae enter the cell via the PGDF receptor and
the EGF receptor, respectively (Elwell et al., 2008; Mölleken
et al., 2013). Both receptors are degraded via the endo-lysosomal
pathway, which is initiated by the Hrs recognition of the poly-
ubiquitinated activated receptor. Bacterial effectors translocated
upon invasion might reach a local concentration sufficient to
bind Hrs (and Tsg101) and prevent the recruitment of the ESCRT
machinery, thereby escaping from the lysosomal pathway. Such
a restriction mechanism has been proposed for an effector of
Mycobacterium tuberculosis (Mehra et al., 2013).
(ii) Hypothesis 2: DUF582 proteins target Hrs/Tsg101 to
acquire material from the host. While Chlamydia imports many
host constituents inside the inclusion, the mechanisms involved
are largely unknown. Here we demonstrated that translocation
of the host glycogen synthase Gys1 did not require the ESCRT
machinery. Importantly, redundant pathways exist to sustain
nutrient acquisition by the chlamydial inclusion (Vromman and
Subtil, 2014). Thus, blocking one ESCRT-driven mechanism
might not necessarily prevent uptake of one substrate, nor impact
bacterial growth, making this second hypothesis compatible with
our results.
(iii) Hypothesis 3: CT619 interacts with Tsg101 for bacterial
exit through extrusion. C. trachomatis exits cells through two
pathways, one being extrusion, that is budding of part of the
inclusion surrounded with plasma membrane, without cell lysis
(Hybiske and Stephens, 2007). Extrusion seems to have many
similarities with cytokinesis, and ends by an abscission-like
process. Cytokinesis requires Tsg101 activity, which is recruited
before abscission to trigger ESCRT-III recruitment (Agromayor
and Martin-Serrano, 2013). Proteins implicated in cytokinesis
(i.e., MLCK and myosin II) have been found to be determinant
for Chlamydia extrusion and their depletion decreases the
number of extrusion events. Thus, secretion of CT619 late in the
cycle could recruit Tsg101 to engage exit through the extrusion
pathway. We have attempted to test this hypothesis but in our
experimental system extrusion represents only a very minor
pathway of cell exit, compared to bacterial lysis, precluding
further analysis of the possible implication of Tsg101 and CT619
in this process.
Irrespective of the functional link between the DUF582
domain and Hrs, this study revealed that the ESCRT machinery
was not required for C. trachomatis development in vitro. We
showed that silencing of essential proteins of the ESCRT-0
(Hrs), -I (Tsg101), and -III (Chmp4B) machineries had no
impact on primary infection, nor on the progeny collected.
Consistently, overexpression of a dominant negative form of
VPS4, an essential player of ESCRT driven processes, had no
impact on bacterial growth. This result is surprising considering
the implication of ESCRT machineries in a wealth of cellular
processes (Hurley, 2015). It does not imply that ESCRT-
driven processes are not co-opted by the bacteria, as proposed
in the last two hypothesis discussed above. However, in a
different perspective, silencing of major constituents of the
ESCRT machinery must have deeply disturbed several cellular
activities of the host. The fact that it had no impact on
bacterial development speaks for the remarkable robustness of
the bacterial development, which, while fully dependent on the
host for many constituents, is able to adapt to deep variations in
cell homeostasis.
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Figure S1 | Distribution of Hrs during C. trachomatis development. HeLa
cells were infected with C. trachomatis L2 (MOI = 0.3) for the indicated times
before fixation on ice in 4% PFA. The inclusion membrane was stained with
anti-CT529 antibodies followed with Alexa488-conjugated anti-rabbit antibodies
(green), Hrs was stained with mouse antibodies followed with Cy5-conjugated
anti-mouse antibodies (red) and DNA was labeled with Hoechst 33342 (blue).
Scale bar = 5µm.
Figure S2 | Effect of the depletion of ESCRT proteins or of expression of
VPS4 DN mutant on EGFRho traffic. HeLa cells, transfected for 48 h with the
indicated siRNA (top and middle panels) or for 24 h with VPS4 DN (bottom panels),
were incubated for 15min at 37◦C with 100 ng/ml EGFRho in DMEM, washed, and
incubated further for 45min in complete medium before fixation in 4% PFA. Cells
transfected with VPS4 DN were permeabilized and stained with Rabbit anti-myc
antibodies followed with Alexa488-coupled anti-rabbit antibodies. For each
condition one representative field in the red channel (EGFRho) is shown. For the
VPS4 DN transfection, expression of the VPS4 DN mutant is verified by anti-myc
staining (bottom right panel). Scale bar = 10µm. Note that the inhibition of the
ESCRT components has distinct effects on the morphology of the EGF-containing
compartments (Razi and Futter, 2006). It also affects the quantity of EGF receptor
that recycles to the cell surface, and its degradation rate. Altogether, interfering
with the activity of ESCRT components affects to various degree the intensity of
the EGFRho signal (very reduced in Chmp4 siRNA treated cells or VPS4 DN
expressing cells), and/or its distribution (scattering vs. clustering of the EGFRho
positive compartments in Hrs and Tsg101 siRNA treated cells respectively).
Table S1 | Primers used in this study.
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